Huabao Wang

This researcher's publication record centers on chronic lymphocytic leukemia (CLL), a slow-growing blood cancer, with a focus on combination drug therapies such as ianalumab and ibrutinib. Other recent work touches on metabolism-related topics including fat tissue transplantation, ammonia's role in tumor growth, and biomarkers in bladder cancer, suggesting involvement in clinical trial research and translational cancer/metabolism studies rather than a single narrow specialty.​

Output was sparse and irregular for most of the past decade (0-1 papers per year) but shows a sharp recent spike in 2025, largely driven by a single major clinical trial paper and its associated supplementary materials.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026